Oncology Clinical Trials in Overland Park, KS
As of August 2026, 33 paid clinical trials are recruiting for Oncology in Overland Park, Kansas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
33 clinical trials for Oncology
·Clear filters·A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Integrated Cancer Repository for Cancer Research
Registry Study for Radiation Therapy Outcomes
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Top Research Study Locations in Overland Park
Researchers run research studies in Overland Park, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Cancer Center-Overland Park | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm | 52 |
| University of Kansas Hospital-Indian Creek Campus | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 37 |
| Kansas City Heart Rhythm Institute | Atrial Fibrillation, Myocarditis, Cardiac Dysautonomia | 10 |
| Overland Park Regional Medical Center | Atrial Fibrillation, Stroke, Autonomic Dysfunction | 10 |
| Kansas City Heart Rhythm Institute - Roe Clinic | Atrial Fibrillation, Stroke, Autonomic Dysfunction | 6 |
| Menorah Medical Center | Atrial Fibrillation, Stroke, Anatomic Stage II Breast Cancer AJCC v8 | 6 |
| Dr. Vince Clinical Research | Healthy Non-dependent, Recreational Sedative Users, Opioid Use Disorder, Peanut Allergy | 5 |
| Midwest Heart and Vascular Specialists | Cardiovascular Disease, Acute Myocardial Infarction (AMI), Cardiac Dysautonomia | 5 |
| Clinical Associates Midwest, LLC | Acute Migraine, Migraine | 4 |
| Collective Medical Research | Acute Migraine, Major Depressive Disorder, Migraine | 3 |
| Saint Luke's South Hospital | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 3 |
| The Kansas City Heart Rhythm Institute | Atrial Fibrillation | 3 |
| Altasciences Clinical Kansas | Opioid Dependence, Opioid Use Disorder (OUD), Safety and Tolerability in Healthy Subjects | 2 |
| Altasciences Clinical Kansas, Inc. | Obesity, Overweight | 2 |
| Delricht Research - Concierge And Direct Primary Care | Gout, Tophaceous Gout | 2 |
| Kansas City Cardiac Arrhythmia Research LLC | Atrial Fibrillation, Diastolic Heart Failure, Heart Failure | 2 |
| Kansas City Eye Clinic | Corneal Endothelial Decompensation, Corneal Transplant Failure, Fuchs Endothelial Corneal Dystrophy | 2 |
| Kansas City Heart Rhythm Institute (Midwest Heart and Vascular Specialist) | Coronary Artery Disease, Paroxysmal AF | 2 |
| Kansas Institute of Research,, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Skin and Hair Center | Hidradenitis Suppurativa, NonSegmental Vitiligo | 2 |
| The University of Kansas Cancer Center - Indian Creek Campus | Acute Myeloid Leukemia, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer | 2 |
| College Park Family Care Center Overland Park | Migraine, Migraine Prophylaxis | 2 |
| AHMG Cardiology and Surgery | Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Altasciences - Kansas City | Cystic Fibrosis | 1 |
| Altasciences Inc - Kansas City | Influenza | 1 |
Active & Upcoming Studies in Overland Park (2026)
Recruiting trials in Overland Park grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (70 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene · Phase 1, Phase 2 · National Cancer Institute (NCI)
Cardiovascular (22 active studies)
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis · Phase 2 · Beijing Inno Medicine Co., Ltd.
Neurology & pain (17 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Vaccines (2 active studies)
- Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine · Phase 3 · Invivyd, Inc.
- First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Mental health & behavior (2 active studies)
Diabetes & metabolic (2 active studies)
- A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight · Phase 1 · Novo Nordisk A/S
- A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity · Phase 2 · Novo Nordisk A/S
Eye & vision (1 active study)
- Hydrus® Microstent New Enrollment Post-Approval Study · Alcon Research
Common conditions studied in Overland Park
- Atrial Fibrillation (11 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Breast Cancer (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Migraine (4 active studies)
Leading research sponsors in Overland Park
- National Cancer Institute (NCI)
- Kansas City Heart Rhythm Research Foundation
- NRG Oncology
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Overland Park?
There are approximately 163 recruiting clinical trials in Overland Park, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Overland Park pay participants?
Most recruiting trials in Overland Park compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Overland Park?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Overland Park?
The most common conditions under active study in Overland Park include Atrial Fibrillation (11), Acute Myeloid Leukemia (6), Stage IV Lung Cancer AJCC v8 (6), Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Overland Park?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Overland Park on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Overland Park?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Overland Park?
Recruiting research sites in Overland Park include University of Kansas Cancer Center-Overland Park, University of Kansas Hospital-Indian Creek Campus, Kansas City Heart Rhythm Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Overland Park right now?
The largest active categories in Overland Park are Cancer & tumors (70), Cardiovascular (22), Neurology & pain (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.